CoChat

Siglec receptors and hiding plaques in Alzheimer's disease

Salminen, Antero, Kaarniranta, Kai · 2009 · Journal of Molecular Medicine

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disease. One hallmark of this disease is the continuous increase in the numbers and size of aggregating amyloid plaques. The accumulation of extracellular plaques is an immunologically interesting phenomenon since microglial cells, brain-specific macrophages, should be able to cleanse the aggregating material from the human brain. Immunotherapy targeting beta-amyloid peptides in plaques with antibodies represents a promising therapy in AD. Recent progress in pattern recognition receptors of monocytes and macrophages has revealed that the sialic acid-binding, immunoglobulin-like lectin (Siglec) family of receptors is an important recognition receptor for sialylated glycoproteins and glycolipids. Interestingly, recent studies have revealed that microglial cells contain only one type of Siglec receptors, Siglec-11, which mediates immunosuppressive signals and thus inhibits the function of other microglial pattern recognition receptors, such as TLRs, NLRs, and RAGE receptors. We will review here the recent literature which clearly indicates that aggregating amyloid plaques are masked in AD by sialylated glycoproteins and gangliosides. Sialylation and glycosylation of plaques, mimicking the cell surface glycocalyx, can activate the immunosuppressive Siglec-11 receptors, as well as hiding the neuritic plaques, allowing them to evade the immune surveillance of microglial cells. This kind of immune evasion can prevent the microglial cleansing process of aggregating amyloid plaques in AD.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00109-009-0472-1

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 47 references

Cited by

See all 73

Metadata

Authors
Salminen, A., & Kaarniranta, K.
Affiliations
University of Eastern Finland (FI)
Corresponding author
Salminen, Antero
Venue
Journal of Molecular Medicine
Published
2009-04-24
Volume
87
Issue
7
Pages
697-701
ISSN
  • 0946-2716 (ISSN-L)
  • 1432-1440
OpenAlex
W2134422863
Cited by
73
References
47
Citations by year
2025: 1 · 2024: 3 · 2023: 5 · 2022: 4 · 2021: 8 · 2020: 3 · 2019: 4 · 2018: 3 · 2017: 2 · 2016: 3 · 2015: 4 · 2014: 1 · 2013: 5 · 2012: 10
FWCI
0.99
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Journal of Molecular Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
Keywords
Alzheimer's disease, Siglec receptors, amyloid plaques, microglia, immune evasion, sialylation, gangliosides, sialic acid-binding lectins, pattern recognition receptors, amyloid-beta, immunosuppression, glycosylation, neuroinflammation
MeSH terms
Alzheimer Disease, Animals, Gangliosides, Glycoproteins, Humans, Models, Biological, Receptors, Immunologic, Lectins, Plaque, Amyloid, Sialic Acid Binding Immunoglobulin-like Lectins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Siglec receptors and hiding plaques in Alzheimer's disease. https://app.cochat.ai/papers/10.1007/s00109-009-0472-1
The paper
Salminen, A., & Kaarniranta, K. (2009). Siglec receptors and hiding plaques in Alzheimer's disease. Journal of Molecular Medicine. https://doi.org/10.1007/s00109-009-0472-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.